BIOMAT Database Logo BIOMAT Database Logo

Hyperacute rejection of orthotopic cardiac allografts in dogs following solubilized antigen pretreatment. 1973

P K Caves, and E Dong, and R E Morris

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

P K Caves, and E Dong, and R E Morris
Hyperacute rejection of heterotopic heart allografts in dogs.
June 1972, Transplantation,
P K Caves, and E Dong, and R E Morris
Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. An experimental study.
February 1973, The American journal of pathology,
P K Caves, and E Dong, and R E Morris
Protective value of heparin in hyperacute rejection of renal allografts in presensitized dogs.
January 1973, Investigative urology,
P K Caves, and E Dong, and R E Morris
Genetics of acute rejection of rat cardiac allografts and a model of hyperacute rejection.
April 1974, Transplantation,
P K Caves, and E Dong, and R E Morris
Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection.
January 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
P K Caves, and E Dong, and R E Morris
Histopathology of rejection in DLA-identical canine orthotopic cardiac allografts.
October 1976, Transplantation,
P K Caves, and E Dong, and R E Morris
Hyperacute rejection in heart allografts. Case studies.
January 1991, Pathology, research and practice,
P K Caves, and E Dong, and R E Morris
Hyperacute rejection following ABO-compatible orthotopic liver transplantation--a case report.
December 1992, Transplantation,
P K Caves, and E Dong, and R E Morris
Lack of significance of allotype differences in hyperacute rejection of rat cardiac allografts.
August 1979, Transplantation,
P K Caves, and E Dong, and R E Morris
Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs.
January 1970, Transplantation,
Copied contents to your clipboard!